Chemoinformaics analysis of Hydroxyacetone
Molecular Weight | 74.079 | nRot | 1 |
Heavy Atom Molecular Weight | 68.031 | nRig | 1 |
Exact Molecular Weight | 74.0368 | nRing | 0 |
Solubility: LogS | 0.883 | nHRing | 0 |
Solubility: LogP | -0.824 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 11 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 5 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 3 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 10.6148 |
nHD | 1 | BPOL | 6.88724 |
QED | 0.458 |
Synth | 2.249 |
Natural Product Likeliness | 0.976 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.053 |
HIA | 0.005 |
CACO-2 | -4.509 |
MDCK | 0.000125843 |
BBB | 0.566 |
PPB | 0.152399 |
VDSS | 0.612 |
FU | 0.862805 |
CYP1A2-inh | 0.075 |
CYP1A2-sub | 0.357 |
CYP2c19-inh | 0.023 |
CYP2c19-sub | 0.483 |
CYP2c9-inh | 0.005 |
CYP2c9-sub | 0.173 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.362 |
CYP3a4-inh | 0.005 |
CYP3a4-sub | 0.186 |
CL | 5.39 |
T12 | 0.911 |
hERG | 0.025 |
Ames | 0.036 |
ROA | 0.344 |
SkinSen | 0.698 |
Carcinogencity | 0.036 |
EI | 0.994 |
Respiratory | 0.162 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.981113 |